Browse Related Topics For:

Hatch-Waxman

167
Pharmaceutical Industry
162
Patents
159
Generic Drugs
143
Pharmaceutical Patents
134
Patent Infringement
119
Patent Litigation
104
ANDA
100
Prescription Drugs
87
FDA
38
SCOTUS
34
Patent-in-Suit
34
Reverse Payment Settlement Agreements
33
FTC
33
FTC v Actavis
20
Pay-For-Delay
19
Mylan Pharmaceuticals
18
Teva Pharmaceuticals
16
BPCIA
16
Personal Jurisdiction
16
Popular
15
Inter Partes Review (IPR) Proceeding
14
Actavis Inc.
14
Antitrust Litigation
14
Biosimilars
13
Sandoz
12
Appeals
12
Patent Trial and Appeal Board
12
Watson Pharmaceuticals
11
AstraZeneca
10
America Invents Act
10
Anti-Competitive
10
Safe Harbors
9
Settlement
8
Apotex
8
Biologics
8
Patent Applications
8
Prior Art
8
Rule-of-Reason Analysis
8
Sherman Act
7
Cephalon
7
Claim Construction
7
DaimlerChrysler v Bauman
7
Eli Lilly
7
FDCA
7
GlaxoSmithKline
7
Otsuka Pharmaceutical
6
Amgen
6
Classen Immunotherapies
6
Declaratory Judgments
6
Merck
6
Novartis
6
Orange Book
6
Preliminary Injunctions
6
Sandoz v Amgen
6
Summary Judgment
6
USPTO
6
Warner Chilcott
5
Antitrust Violations
5
Bayer
5
Class Action
5
Corporate Counsel
5
Endo Pharmaceuticals
5
FDA Approval
5
Hospira
5
Infringement
5
Motion to Dismiss
5
No-AG Agreement
5
Obviousness
5
Patent Reform
5
Patent-Eligible Subject Matter
5
Preemption
5
Teva v Sandoz
4
Allergan Inc
4
Elan Pharmaceuticals
4
Federal Rule 12(b)(6)
4
Induced Infringement
4
Jurisdiction
4
Labeling
4
Patent Dance
4
Patent Invalidity
4
Pleading Standards
4
Product Hopping
4
Standard of Review
4
Takeda Pharmaceuticals
3
Antitrust Provisions
3
Biologics Price Competition and Innovation Act of 2009
3
Biotechnology
3
Certiorari
3
Commercial Marketing
3
De Novo Standard of Review
3
Discovery
3
Disgorgement
3
Dismissals
3
Exclusivity
3
Failure To Warn
3
Healthcare
3
Hedge Funds
3
Innovation Act
3
Manufacturers
3
Minimum Contacts
3
Notice Requirements
3
Patent Trolls
3
Putative Class Actions
3
Reverse Payments
3
Specific Jurisdiction
3
Spectrum
3
Standing
3
Subject Matter Jurisdiction
3
Unfair Competition
2
aBLA
2
Allergan v Sandoz
2
Amarin
2
Article III
2
Biogen Idec
2
Brand
2
Broadest Reasonable Interpretation Standard
2
Burden of Proof
2
CA Supreme Court
2
Cartwright Act
2
Competition
2
DaimlerAG
2
Damages
2
Disclosure Requirements
2
Doctrine of Equivalents
2
Estoppel
2
Forum Shopping
2
Fresenius
2
Generic
2
Genzyme
2
Injunctions
2
Innovation
2
Intellectual Property Litigation
2
Intellectual Property Protection
2
Licensing Rules
2
Life Sciences
2
Mayo v. Prometheus
2
Medicare Modernization Act
2
Monopolization
2
Motion To Stay
2
Mutual Pharmaceuticals v Bartlett
2
Nexium
2
Non-Practicing Entities
2
Noninfringement
2
On-Sale Bar
2
Orphan Drugs
2
Pfizer
2
PLIVA v Mensing
2
Presumption of Validity
2
Product Exclusivity
2
Proposed Regulation
2
Roxane Laboratories
2
Shire Development v Watson
2
SmithKline Beecham
2
SNDAs
2
Validity
2
Written Descriptions
1
Abbott Laboratories
1
AbbVie
1
Abuse of Process
1
Affordable Care Act
1
Amicus Briefs
1
AMP v Myriad
1
Annual Reports
1
Antibiotics
1
Antitrust Conspiracies
1
Antitrust Injuries
1
Antitrust Standing
1
Attorney Disbarrment
1
Attorney-Client Privilege
1
Australia
1
Automatic Stay
1
Balancing Test
1
Bifurcation
1
Biofuel
1
Biopharmaceutical
1
Bipolar Disorder
1
Boehringer
1
Bowman v Monsanto
1
Burden-Shifting
1
But For Causation
1
CAFA
1
Cancer
1
Chevron Deference
1
Cipro
1
Cisco v CommilUSA
1
Claim Preclusion
1
Class Certification
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Clinical Trials
1
CLS Bank v Alice Corp
1
Coca Cola
1
Collateralized Debt Obligations
1
Combination Products
1
Comment Period
1
Compliance
1
Congressional Committees
1
Consent Order
1
Consideration
1
Contraceptives
1
Controlled Substances Act
1
Counterclaims
1
Covered Business Method Patents
1
Covered Business Method Proceedings
1
Cuozzo Speed Technologies
1
Cuozzo Speed Technologies v Lee
1
Dart Cherokee Basin Operating Co. v. Owens
1
Data Protection
1
DEA
1
Death Penalty
1
Dell
1
Design Defects
1
Design Patent
1
Direct Purchasers
1
Dirks v SEC
1
Discovery Schedule
1
DNA
1
Drug Approvals
1
Drug Compounding
1
Drug Safety
1
Duty to Deal
1
Duty to Update
1
eBay
1
Emerging Markets
1
Employer Mandates
1
Enforcement
1
Enforcement Actions
1
Enforcement Statistics
1
EPA
1
European Patent Office
1
Exemptions
1
Expert Testimony
1
Exports
1
Extrinsic Evidence
1
Fair Market Value
1
False Advertising
1
Federal Jurisdiction
1
Federal Rule 12(b)(1)
1
Federal Rules of Civil Procedure
1
Financial Crisis
1
Foreign Corporations
1
Foreign Defendants
1
Forest Laboratories
1
Forum
1
Forum Non Conveniens
1
Forum Selection
1
Fraud
1
General Jurisdiction
1
Goodyear
1
Hague Convention
1
Healthcare Costs
1
Hindsight Reconstruction
1
Human Genes
1
India
1
Injury-in-Fact
1
Innovator Liability
1
Insider Trading
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Internal Investigations
1
Inventions
1
ITC
1
Jazz Pharmaceuticals
1
Joinder
1
Jury Verdicts
1
Justiciable Controversy
1
KBR (formerly Kellogg Brown & Root)
1
Laches
1
Lanham Act
1
Leave to Amend
1
License Agreements
1
Loss Causation
1
Manufacturing Defects
1
Market Manipulation
1
Marketing
1
Markman Hearing
1
Material Misrepresentation
1
Medical Devices
1
Medical Research
1
Method Claims
1
Misrepresentation
1
Monsanto
1
Morgan Stanley
1
Motion for Reconsideration
1
Motion to Amend
1
Myriad
1
New Trial
1
Nintendo
1
Non-Appealable Decisions
1
Off-Label Use
1
Omissions
1
Omnicare v Laborers District Council
1
Opioid
1
Out-of-State Companies
1
OxyContin
1
Par Pharmaceutical
1
Patent Agent Privilege
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Term Adjustment
1
Patent Term Extensions
1
Patent-Misuse
1
Patentability Search
1
Pending Legislation
1
Permanent Injunctions
1
Personal Benefit
1
Petition For Rehearing
1
PHRMA
1
Pleadings
1
POM Wonderful
1
Post-Grant Review
1
Premarket Approval Applications
1
Presidential Elections
1
Price Manipulation
1
Prilosec
1
Prioritized Examination
1
Privilege Waivers
1
Proctor & Gamble
1
Product Defects
1
Product Labels
1
Product of Nature Doctrine
1
Professional Conferences
1
Prometheus
1
Proposed Amendments
1
Quality Control Plan
1
RanBaxy
1
Registration Requirement
1
Regulatory Agenda
1
Reissue Patents
1
Removal
1
Research and Development
1
Restraining Orders
1
Reversal
1
RICO
1
Ripeness
1
ROI
1
Royalties
1
Rule 26
1
Rulemaking Process
1
Sales Contracts
1
Sanofi
1
Scienter
1
Scope of Discovery Requests
1
Section 337
1
Settlements
1
Sham Litigation Exception
1
Single Occurrence
1
Standard of Proof
1
State Law Tort Claims
1
STRONG Patents Act
1
Supplemental Examination
1
Supply Chain
1
Tolling
1
Trademark Infringement
1
TRIPS Agreement
1
TRO
1
Tyco
1
Uniform Commercial Code (UCC)
1
USDA
1
Vacated
1
Vaccinations
1
Valuation
1
Veterinarians
1
Veterinary Products
1
Warning Labels
1
White Collar Crimes
1
WIPO
1
Work Product Privilege
1
World Intellectual Property Organisation
1
Young Lawyers